Noise phobia—intense fear responses to specific sounds such as fireworks, thunderstorms, or gunshots—affects an estimated 20-50% of dogs. It causes significant acute suffering and, in chronic cases, persistent anxiety with profound welfare implications.
Noise phobia is mediated through the amygdala-centred fear circuit, triggering sympathetic nervous system activation (fight-or-flight response). Dogs with noise phobia show rapid cortisol spikes, cardiac acceleration, hyperventilation, and behavioural signs including trembling, panting, pacing, hiding, attempting escape, urination, and defaecation. The emotional experience is genuine terror—not "attention-seeking" or "dramatic" behaviour.
Breed predisposition exists, with herding breeds and Nordic breeds showing elevated prevalence. Inadequate sound habituation during the sensitive socialisation period (3-12 weeks) increases risk. Single traumatic sound experiences can cause conditioned fear responses. Co-morbid anxiety disorders (separation anxiety, generalised anxiety) are common. Older dogs may develop noise phobia de novo due to age-related nervous system changes.
During noise events, creating a safe retreat—preferably a dark, confined space the dog has chosen—reduces environmental stimulation. Compression garments (Thundershirts) provide calming pressure in some dogs. Pheromone diffusers (DAP/Adaptil) reduce background anxiety. Desensitisation audio programmes can be left at low volume as a calming distractor. Attempting to distract or engage fearful dogs in training is counterproductive during peak fear.
For predictable noise events (fireworks, fireworks seasons), situational medication administered 1-2 hours before anticipated exposure significantly reduces suffering. Imepitoin (Pexion) has a specific indication for noise phobia in dogs and reduces fear without heavy sedation. Trazodone provides anxiolysis. Alprazolam (benzodiazepine) can be used situationally. Historical acepromazine use is now discouraged—it causes chemical restraint without reducing fear experience.
Outside trigger seasons, systematic desensitisation using recorded trigger sounds (starting at sub-threshold volume) combined with counter-conditioning (high-value food, play) progressively reduces fear responses. Commercial programmes (Sounds Scary, Dogs Trust audio programmes) provide structured protocols. Progress is gradual and must remain sub-threshold throughout. Concurrent anxiolytic medication during the desensitisation programme often improves outcomes.
In severely affected dogs or those with co-morbid anxiety disorders, daily SSRI therapy (fluoxetine, paroxetine) reduces background anxiety, improving responsiveness to behavioural modification and reducing the severity of acute noise responses. Combined pharmacological and behavioural approaches produce better outcomes than either alone.